Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer
Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer
Prostate Cancer
Hormonal sensitivity to second line treatment for CaP after Bicalutamide, six months
median duration of second and third line treatments;, six months
Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer